Literature DB >> 3932190

The effect of phenytoin in vitro on normal human mononuclear cells and on human lymphoblastoid B cell lines of different Ig isotype specificities.

A G Wangel, H Arvilommi, I Jokinen.   

Abstract

The anticonvulsant drug phenytoin, in less than cytotoxic concentrations, caused significant reductions in Ig secretion by unstimulated or EBV-stimulated normal MNC, as measured by PFC or secretion of Ig into the culture medium. Isotype-specific LBL varied in their sensitivity, the secretion of IgA (1 line) and IgG (3 lines) being reduced by phenytoin near therapeutic concentrations, whereas that of IgM (1 line) was resistant. Six-day exposure of MNC to phenytoin caused no selective depletion of or enrichment for B cells, monocytes or T cell subsets. The results suggest that the reduction in serum Ig levels reported in phenytoin-treated epileptic patients is, at least in part, due to a direct effect of the drug on the B lymphocyte. However, among EBV-activated normal MNC, those secreting IgA were no more sensitive to the drug than those secreting IgG or IgM, and other factors may, therefore, operate to cause the preferential reduction in serum IgA in phenytoin-treated patients.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3932190     DOI: 10.1016/S0171-2985(85)80094-2

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  3 in total

1.  Anticonvulsant-induced suppression of IFN-gamma production by lymphocytes obtained from cervical lymph nodes in glioma-bearing mice.

Authors:  M Yamada; M Ohkawa; K Tamura; E Mabuchi; H Kishima; M Tamura; K Shimizu
Journal:  J Neurooncol       Date:  2000-04       Impact factor: 4.130

2.  Enhancement in number and function of antigen-presenting cells in the lymphatic tissue of rats after in vivo administration of diphenylhydantoin (DPH).

Authors:  S Petrasch; H H Wacker; P Zou; D Bechtold; G Brittinger
Journal:  Clin Exp Immunol       Date:  1989-10       Impact factor: 4.330

3.  Effects of phenytoin on cell-mediated immunity.

Authors:  Y Okamoto; K Shimizu; K Tamura; Y Miyao; M Yamada; N Tsuda; Y Matsui; H Mogami
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.